Nevertheless, BCR-ABL-independent mechanisms underlying the persistence of quiescent CML stem cells or the alterations of efflux/influx pumps have also been observed [3]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.